As the majority of patients with type 2 diabetes are overweight or obese this offers a potential advantage over older, established therapies, and DPP-4 inhibitors are being used in clinical practice as second-line therapy in addition to metformin in overweight and obese patients who fail to reach glycemic targets with metformin monotherapy
Conclusion In conclusion, our study findings suggest that the use of GLP-1RAs may offer significant benefits for patients who have undergone bariatric surgery and are facing WR or IWL Additionally, it is important to highlight that the safety profile of these medications was favorable, with no significant adverse events reported
She carefully monitors your progress, provides nutritional recommendations, and adjusts dosages as needed to ensure your body responds safely and effectively
A permissive apoptotic environment: function of a decrease in intracellular superoxide anion and cytosolic acidification
But melanoma does not always respond to chemotherapy
This isn't a slow, constant trickle